Skip to content
healthcare.dev
Get a free key

POTASSIUM CITRATE

NDC 16571-865, potassium citrate, tablet, extended release, from Rising Pharma Holdings, Inc..

Product NDC
16571-865
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077440
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-865 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POTASSIUM CITRATE1080 mg/1

Pharmacologic classes

Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]

Package NDCNDC-11Package
16571-865-0116571086501100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-865-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/164d9d05-fbb1-4d99-8ba3-ff9c172aa8ca

  • NADAC price for package 16571086501

    GET /v1/drugs/nadac/16571086501

Use it

Look up 16571-865 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-865 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-865. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.